BlockBeats news, on April 1, the decentralized protocol Bio Protocol, aimed at early-stage biotechnology, announced the launch of its first major protocol upgrade – Bio V1 on Solana and Base. V1 introduces several features designed to simplify and optimize early-stage biotechnology financing and development, and to increase novel incentive mechanisms, including: · A community-governed Launchpad for early financing; · A liquidity and incentive engine that supports instant liquidity post-financing and rewards linked to scientific milestones; · BioAgents, AI-driven agents capable of automating research tasks such as R&D data analysis and experimental design. BIO token holders can decide which biotechnology projects get launched and their direction of development. In return, they gain priority access to early allocations of successful projects on the network. During the selection process, BIO token holders determine which new BioDAOs can receive funding on the Bio V1 launchpad. Investing in BIO will grant discounts on BioDAO tokens.
Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to
Disclaimer.
